Codexis Enters $60MM Term Loan Facility with Trinity Capital

Codexis’s $60 million term loan facility with Trinity Capital underscores ongoing lender appetite for middle-market biotech borrowers despite sector volatility. The deal highlights how specialized credit providers continue to support growth-stage companies through structured financing solutions. For middle-market credit professionals, this transaction signals sustained demand for tailored term loans in innovation-driven industries, reflecting confidence in borrowers with strong growth prospects and the ability to secure sizable capital injections outside traditional equity markets.